Cargando…

Primary and secondary angiosarcomas: a comparative single-center analysis

BACKGROUND: Angiosarcomas (AS) are rare vascular malignancies. They are subdivided into primary (PAS) and secondary angiosarcomas (SAS). The objective was to compare the characteristics of AS subtypes. METHODS: Eighteen PAS and ten SAS patients treated at our institution between 2004 and 2012 were i...

Descripción completa

Detalles Bibliográficos
Autores principales: Hillenbrand, Thorsten, Menge, Franka, Hohenberger, Peter, Kasper, Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582641/
https://www.ncbi.nlm.nih.gov/pubmed/26413264
http://dx.doi.org/10.1186/s13569-015-0028-9
_version_ 1782391736675336192
author Hillenbrand, Thorsten
Menge, Franka
Hohenberger, Peter
Kasper, Bernd
author_facet Hillenbrand, Thorsten
Menge, Franka
Hohenberger, Peter
Kasper, Bernd
author_sort Hillenbrand, Thorsten
collection PubMed
description BACKGROUND: Angiosarcomas (AS) are rare vascular malignancies. They are subdivided into primary (PAS) and secondary angiosarcomas (SAS). The objective was to compare the characteristics of AS subtypes. METHODS: Eighteen PAS and ten SAS patients treated at our institution between 2004 and 2012 were included in this study. RESULTS: Median age of PAS and SAS patients was 52.9 and 64.2 years, respectively (p = 0.1448). The percentage of women was 27.8% for PAS, but 80.0% for SAS (p = 0.0163). While PAS occurred throughout the body, the majority of SAS arose from the breast (p = 0.0012). All SAS were radiation-induced with a median latency of 7.7 years. The majority of patients with PAS and SAS underwent surgery as primary or recurrence treatment (p > 0.95). Local recurrence was developed by 27.8% of PAS and 50.0% of SAS (p = 0.4119). 61.1% of PAS metastasized, but only 40.0% of SAS (p = 0.4328). Median overall survival for PAS and SAS was 19 and 57 months, respectively (p = 0.2306). CONCLUSION: Radical surgery remains the mainstay of both primary and recurrence treatment. SAS show a high local recurrence rate, while PAS tend towards developing early metastases. Overall, prognosis is poor for both groups.
format Online
Article
Text
id pubmed-4582641
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45826412015-09-26 Primary and secondary angiosarcomas: a comparative single-center analysis Hillenbrand, Thorsten Menge, Franka Hohenberger, Peter Kasper, Bernd Clin Sarcoma Res Research BACKGROUND: Angiosarcomas (AS) are rare vascular malignancies. They are subdivided into primary (PAS) and secondary angiosarcomas (SAS). The objective was to compare the characteristics of AS subtypes. METHODS: Eighteen PAS and ten SAS patients treated at our institution between 2004 and 2012 were included in this study. RESULTS: Median age of PAS and SAS patients was 52.9 and 64.2 years, respectively (p = 0.1448). The percentage of women was 27.8% for PAS, but 80.0% for SAS (p = 0.0163). While PAS occurred throughout the body, the majority of SAS arose from the breast (p = 0.0012). All SAS were radiation-induced with a median latency of 7.7 years. The majority of patients with PAS and SAS underwent surgery as primary or recurrence treatment (p > 0.95). Local recurrence was developed by 27.8% of PAS and 50.0% of SAS (p = 0.4119). 61.1% of PAS metastasized, but only 40.0% of SAS (p = 0.4328). Median overall survival for PAS and SAS was 19 and 57 months, respectively (p = 0.2306). CONCLUSION: Radical surgery remains the mainstay of both primary and recurrence treatment. SAS show a high local recurrence rate, while PAS tend towards developing early metastases. Overall, prognosis is poor for both groups. BioMed Central 2015-05-23 /pmc/articles/PMC4582641/ /pubmed/26413264 http://dx.doi.org/10.1186/s13569-015-0028-9 Text en © Hillenbrand et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Hillenbrand, Thorsten
Menge, Franka
Hohenberger, Peter
Kasper, Bernd
Primary and secondary angiosarcomas: a comparative single-center analysis
title Primary and secondary angiosarcomas: a comparative single-center analysis
title_full Primary and secondary angiosarcomas: a comparative single-center analysis
title_fullStr Primary and secondary angiosarcomas: a comparative single-center analysis
title_full_unstemmed Primary and secondary angiosarcomas: a comparative single-center analysis
title_short Primary and secondary angiosarcomas: a comparative single-center analysis
title_sort primary and secondary angiosarcomas: a comparative single-center analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582641/
https://www.ncbi.nlm.nih.gov/pubmed/26413264
http://dx.doi.org/10.1186/s13569-015-0028-9
work_keys_str_mv AT hillenbrandthorsten primaryandsecondaryangiosarcomasacomparativesinglecenteranalysis
AT mengefranka primaryandsecondaryangiosarcomasacomparativesinglecenteranalysis
AT hohenbergerpeter primaryandsecondaryangiosarcomasacomparativesinglecenteranalysis
AT kasperbernd primaryandsecondaryangiosarcomasacomparativesinglecenteranalysis